EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Refractory infantile IPEX with Treg-restricted FOXP3null expression caused by a novel variant in FOXP3

Ahmad Rayes iD, Akshaya Ramachandran iD, Michael A Pulsipher iD, J Gregory Dolan iD, Soohee Cho iD, Amanda K Johnson iD, Jessie L Alexander iD, Simon Borna iD, Rosa Bacchetta iD

Journal of Human Immunity · 04.05.2026 · 2 (3)

DOI: 10.70962/jhi.20250249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Human Immunity, online erschienen am 27.03.2026. Verfasst von Ahmad Rayes und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Immunology and Hematopoietic Cell Transplantation/Cellular Therapy Program, Primary Children's Hospital, University of Utah, Salt Lake City…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, National Cancer Institute.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome is a life-threatening monogenic inborn error of immunity caused by pathogenic variants in the FOXP3 gene. In this report, we describe the clinical and immunologic consequences of a novel FOXP3 variant in an infant with refractory IPEX syndrome. Rapid whole-genome sequencing revealed a missense variant c.1050C>G (p.Ile350Met) in the forkhead domain of FOXP3. FOXP3 expression was abrogated in the regulatory T cell (Treg) subset but was maintained at low levels in activated effector T cells. The frequency of Treg-specific demethylated region (TSDR)–demethylated T cells was within normal range at birth, but it increased to pathologically high levels at 2 wk of age, prior to manifestation of disease symptoms. These results support the clinical relevance of the TSDR-demethylated cell percentage in evaluation of disease activity in IPEX. This case highlights a severe form of IPEX syndrome refractory to multiple immunosuppressive agents and the importance of early immunological studies to verify the clinical significance of novel genetic findings.

Autor:innen und Institutionen

  • Pediatric Immunology and Hematopoietic Cell Transplantation/Cellular Therapy Program, Primary Children's Hospital, University of Utah, Salt Lake City, UT, USA.
  • Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA.
  • Huntsman Cancer Institute, Spencer Fox Eccles School of Medicine at the University of Utah, Salt Lake City, UT, USA.
  • Center for Definitive and Curative Medicine, Stanford University, Stanford, CA, USA.
  • Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA.

ORCID-Profile: Ahmad Rayes, Akshaya Ramachandran, Michael A Pulsipher, J Gregory Dolan, Soohee Cho, Amanda K Johnson, Jessie L Alexander, Simon Borna, Rosa Bacchetta

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Cancer Institute
  • Bonnie Uytengsu and family endowment

Zitieren

APA

Rayes, A., Ramachandran, A., Pulsipher, M. A., Dolan, J. G., Cho, S., Johnson, A. K., Alexander, J. L., Borna, S., & Bacchetta, R. (2026). Refractory infantile IPEX with Treg-restricted FOXP3null expression caused by a novel variant in FOXP3. Journal of Human Immunity, 2(3). https://doi.org/10.70962/jhi.20250249

Vancouver

Rayes A, Ramachandran A, Pulsipher MA, Dolan JG, Cho S, Johnson AK, et al. Refractory infantile IPEX with Treg-restricted FOXP3null expression caused by a novel variant in FOXP3. Journal of Human Immunity. 2026;2(3). doi:10.70962/jhi.20250249

BibTeX
@article{Rayes2026,
  author = {Rayes, Ahmad and Ramachandran, Akshaya and Pulsipher, Michael A and Dolan, J Gregory and Cho, Soohee and Johnson, Amanda K and Alexander, Jessie L and Borna, Simon and Bacchetta, Rosa},
  title = {Refractory infantile IPEX with Treg-restricted FOXP3null expression caused by a novel variant in FOXP3},
  journal = {Journal of Human Immunity},
  year = {2026},
  volume = {2},
  number = {3},
  doi = {10.70962/jhi.20250249}
}
Kostenlos starten →